Management of cutaneous metastases using electrochemotherapy
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Management of cutaneous metastases using electrochemotherapy. / Matthiessen, Louise Wichmann; Chalmers, Richard Ling; Sainsbury, David Christopher George; Veeramani, Sivakumar; Kessell, Gareth; Humphreys, Alison Claire; Bond, Jane Elisabeth; Muir, Tobian; Gehl, Julie.
In: Acta Oncologica, Vol. 50, No. 5, 2011, p. 621-9.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Management of cutaneous metastases using electrochemotherapy
AU - Matthiessen, Louise Wichmann
AU - Chalmers, Richard Ling
AU - Sainsbury, David Christopher George
AU - Veeramani, Sivakumar
AU - Kessell, Gareth
AU - Humphreys, Alison Claire
AU - Bond, Jane Elisabeth
AU - Muir, Tobian
AU - Gehl, Julie
PY - 2011
Y1 - 2011
N2 - Cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. Electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. Electrochemotherapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. For the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. The primary endpoint of this study is to evaluate the efficacy of electrochemotherapy as a palliative treatment.
AB - Cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. Electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. Electrochemotherapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. For the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. The primary endpoint of this study is to evaluate the efficacy of electrochemotherapy as a palliative treatment.
U2 - http://dx.doi.org/10.3109/0284186X.2011.573626
DO - http://dx.doi.org/10.3109/0284186X.2011.573626
M3 - Journal article
VL - 50
SP - 621
EP - 629
JO - Acta Oncologica
JF - Acta Oncologica
SN - 1100-1704
IS - 5
ER -
ID: 40153336